Filing Details
- Accession Number:
- 0001209191-15-024532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-10 16:05:59
- Reporting Period:
- 2015-03-05
- Filing Date:
- 2015-03-10
- Accepted Time:
- 2015-03-10 16:05:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1488613 | Foundation Medicine Inc. | FMI | Services-Medical Laboratories (8071) | 271316416 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585018 | W. Robert Hesslein | 150 Second Street C/O Foundation Medicine, Inc. Cambridge MA 02141 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-05 | 4,635 | $47.24 | 68,125 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected to cover the tax liabilities of the reporting person in connection with the exercise of stock options. The reporting person exercised stock options on March 2, 2015 in order to participate in the tender offer commenced by Roche Holdings, Inc. on February 2, 2015.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.20 to $47.27, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.